CASE COMMENTS: EUROPEAN AND INTERNATIONAL LAW – USA – PUBLIC ENFORCEMENT – CARTEL – PAY-FOR-DELAY

United States: The Federal Trade Commission rules that two pharmaceutical laboratories concluded a pay-for-delay agreement (Impax Laboratories)

Aucun relâchement à l’égard des accords de report d’entrée, tels semblent être les consignes données aux agents de la FTC. Dans son Opinion rédigée par Noah Joshua Phillips, l’autorité américaine de la concurrence a jugé à l’unanimité le 28 mars dernier que le laboratoire générique Impax a conclu un accord pay-for-delay illégal avec le laboratoire Endo (pour une étude

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Walid Chaiehloudj, United States: The Federal Trade Commission rules that two pharmaceutical laboratories concluded a pay-for-delay agreement (Impax Laboratories), 28 March 2019, Concurrences Review N° 2-2019, Art. N° 90539, pp. 208

Visites 82

All reviews